LM-VS™ service for Hit Discovery is open!
Hit Discovery with LM-VS™
Go to LM-VS™
Visit Now
Platform
Business
Investors
Newsroom
Company
ENG
Platform
Business
Investors
Newsroom
Company
ENG
Supercomputing
Power
Big Data
AI Software
Accelerating
Bio Innovation
Our AI-powered platforms accelerate the entire drug discovery process — enabling faster,
more precise innovation across small molecules, antibodies, and cancer vaccines.
AI Software
AI-Driven Drug Discovery Platform
Big Data
Language Model and STB Cloud
Supercomputing Power
AI Bio Supercom Center
Syntekabio in Numbers
Drug Discovery Acceleration
3x
Patent Portfolio
30
Global Partnerships
30
Korea AI Bio Supercomputing Center
1 & Only
1 & Only
1 & Only
Latest News
Syntekabio Expects KRW 2 Billion Annual Revenue from Patented Data Center System
Eco-Friendly “Termite-Inspired” Data Center Design Receives Patent Registration
2025.09.02
#
Syntekabio
#
Data Center
#
Patent
Syntekabio Expects KRW 2 Billion Annual Revenue from Patented Data Center System
Eco-Friendly “Termite-Inspired” Data Center Design Receives Patent Registration
2025.09.02
#
Syntekabio
#
Data Center
Syntekabio Sees Smooth Domestic & International Deals… Accelerated Revenue Growth with Next‑Gen Platforms
Targeting next‑generation markets with its antibody optimization and cancer vaccine discovery platforms
2025.08.27
#
Syntekabio
#
NextGenPlatform
#
Biotech
Syntekabio Sees Smooth Domestic & International Deals… Accelerated Revenue Growth with Next‑Gen Platforms
Targeting next‑generation markets with its antibody optimization and cancer vaccine discovery platforms
2025.08.27
#
Syntekabio
#
NextGenPlatform
Syntekabio Posts ₩1.2 Billion Revenue in First Half of the Year
Over ₩1.0 Billion in revenue generated from AI drug discovery platform DeepMatcher
2025.08.13
#
Syntekabio
#
DeepMatcher
#
AI Drug Discovery
Syntekabio Posts ₩1.2 Billion Revenue in First Half of the Year
Over ₩1.0 Billion in revenue generated from AI drug discovery platform DeepMatcher
2025.08.13
#
Syntekabio
#
DeepMatcher
Global Premier AI
Drug Partner
Innovate with us.
Contact Us
Contact Us
© Syntekabio Co., Ltd. All rights reserved.
General Inquiries
Investor Relations / Press
Business Development / Partnerships
Data Center
Family Sites
© Syntekabio Co., Ltd. All rights reserved.